AzTrials
AzTrials

Carotid StenosisCAS-AOCTNCT05835869

Chorioretinal Vascularization and Electrophysiological Changes After Carotid Revascularization

A study testing Optical coherence tomography angiography and pattern electroretinogram in people with Carotid Stenosis, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate changes in retinal function by means of electro-functional examinations of the retina and to associate them with any changes in chorioretinal vascular density occurring in the ipsilateral eye after carotid revascularization surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Carotid Stenosis
What is being tested?
Optical coherence tomography angiography and pattern electroretinogram
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
20 Apr 2023to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age >18 years old
  • Carotid stenosis diagnosis with indication to perform carotid endarterectomy
  • informed consent form signing

Who cannot join

  • age <18 years old
  • recurrent intraocular inflammation
  • retinal disease
  • optic neuropathy, optic nerve drusen, opacity of the dioptric means in the pre- or post-operative period that prevents the acquisition of high-resolution images
  • unstable fixation
  • spheric refractive error > +/- 6 D spheric and/or +/- 3 D cylinder
  • history of prior ocular surgery
  • refusal of signing informed consent form

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting
  • Policlinico Agostino Gemelli IRCCS

    Roma, RM, 00168

    Antonio Baldascino, MD, +393388771472, antonio.baldascino@policlinicogemelli.it

    Recruiting

Other trials in Italy

About this study

Official title: Electrophysiological and Morphofunctional Changes of Retina and Choroid Vascularization After Carotid Endarterectomy, a Pilot Study

The aim of the study is to evaluate changes in retinal function by means of electro-functional examinations of the retina and to associate them with any changes in chorioretinal vascular density occurring in the ipsilateral eye after carotid revascularization surgery.

Being tested
Optical coherence tomography angiography and pattern electroretinogram
Medical subject headings
Carotid Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Optical coherence tomography angiography and pattern electroretinogramDiagnostic test

    Optical coherence tomography angiography is an infrared eye scan that analyzes retinal vascularization and anatomy

Study groups in NCT05835869
Study groupRoleWhat they receive
Study populationExperimentalNot described
Receives: Diagnostic Test: Optical coherence tomography angiography and pattern electroretinogram

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional retinal changes

    To evaluate rate of pattern electroretinography/pattern visual evoked potential improvement in both eyes before and after carotid endarterectomy

    Measured: 1 week and 3 months

Secondary outcomes (1)
  1. Retinal vascular density changes

    To evaluate rate of chorioretinal vascular density improvement trough angiographic optical coherence tomography before and after carotid endarterectomy

    Measured: 1 week and 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2023
  2. Study start20 Apr 2023
  3. Primary completion1 Jul 2023 (estimated)
  4. Study completion30 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05835869
Sponsor's protocol ID
5532
Acronym
CAS-AOCT
Status last verified
Apr 2023
First submitted
19 Apr 2023
Last updated
6 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Optical coherence tomography angiography and pattern electroretinogram in people with Carotid Stenosis, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Antonio Baldascino, MD (+393388771472, antonio.baldascino@policlinicogemelli.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional retinal changes (time frame: 1 week and 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in